Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Three randomised trials of lixisenatide treatment added to basal insulin showed significantly improved glycemic control over placebo, with pronounced postprandial glucose reductions and good tolerability
Individual results vary depending on starting weight, dose, duration, lifestyle, and metabolic factors
Funding No funding was provided for this study
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-4-83ab587c91ea4eab9e89a0e86add8e41.jpg)
Supriya Rao, MD, is a board-certified physician in internal medicine, gastroenterology, obesity medicine, and lifestyle medicine
FAQ highlights: Not everyone responds
US$ 24.18
US$ 20.87
US$ 21.75
US$ 24.19
US$ 20.19
US$ 22.10
US$ 29.93
